Get the Daily Brief
Latest Biotech News
FDA delay that derailed Kezar’s autoimmune hepatitis trial and sale process
Kezar Life Sciences was forced to shut down after the FDA’s four-month delay in a key trial-design meeting arrived too late for its autoimmune hepatitis program. The company said it had reached an...
Oral GLP-1 approval sparks immediate market debate for Eli Lilly’s Foundayo
Eli Lilly’s oral GLP-1 obesity drug Foundayo (orforglipron) won FDA approval, but the initial stock reaction faded as analysts debated how fast prescriptions can build. The report said Lilly...
Pinnacle Medicines raises $89M to advance oral peptide programs modeled after injectable biologics
Pinnacle Medicines added $89 million to fund peptide drugs designed to combine biologic-like efficacy with oral small-molecule dosing convenience. The startup’s lead program—built within...
Real-world safety evidence expands for second-line diabetes drugs in elderly patients
New real-world evidence published in Nature Communications is adding to safety comparisons for second-line antihyperglycemic agents in older adults with type 2 diabetes. The study, led by Kim, Bu,...
Whole-body diffusion MRI predicts outcomes after neoadjuvant chemotherapy in advanced ovarian cancer
A study in the British Journal of Cancer reports that whole-body diffusion-weighted MRI (WB-DWI/MRI) can predict treatment outcomes in advanced ovarian cancer following neoadjuvant chemotherapy....
Distributed computing framework targets breast cancer recurrence prediction using multi-institution data
Researchers unveiled a distributed fusion framework designed to predict breast cancer recurrence using MapReduce-style processing for large datasets. The work, described as a distributed fusion...
Glycocholic acid identified as a lever on colorectal immunotherapy efficacy
A study highlighted circulating glycocholic acid (GCA) as a key modulator of immune checkpoint therapy efficacy in colorectal cancer. The report describes new mechanistic findings linking...
Healthcare AI deployment blueprint centers on workflow fit and proprietary data
A new perspective piece from Flare Capital Partners argues that healthcare AI winners will be determined less by model novelty and more by deployment readiness—especially integration into clinical...
Epidemiology study flags rising therapy-related acute myeloid leukemia incidence in Japan
A population-based epidemiological investigation in Japan reports an escalation in therapy-related acute myeloid leukemia (tAML) incidence over three decades. The study focuses on secondary blood...
Startup-agnostic safety and trial operations insight: reloadable cards emerge as a study-participant incentive tool
A practical trial-operations report argues that reloadable payment cards can outperform cash or one-time checks for compensating clinical trial participants. The piece focuses on tracking,...
Oral GLP-1 approval stokes near-term competition questions
Eli Lilly won FDA approval for its oral obesity drug Foundayo (orforglipron), but a quick post-approval stock bounce faded as investors focused on execution and pricing against Novo Nordisk’s oral...
Financing for oral peptides aims to mimic injectable performance
Pinnacle Medicines raised $89 million to advance oral peptide therapeutics engineered to deliver injectable-biologic-like properties. The startup says its lead program, incubated with OrbiMed, is...
AI system maps likely breast cancer recurrence across distributed data
A new distributed fusion framework for predicting breast cancer recurrence uses MapReduce-style computing to combine data across sites, according to researchers behind a recent report. The...
New prostate/thyroid immunotherapy signal in advanced thyroid cancer
Researchers reported results from the phase II GETNE-DUTHY trial evaluating durvalumab plus tremelimumab in advanced thyroid cancer. The study, led by Capdevila, Hernando, and Molina-Cerillo,...
Immune checkpoint response enhanced by metabolic bile acid modulation
A study reports that blocking circulating glycocholic acid (GCA) can enhance colorectal cancer immunotherapy efficacy. The work links a specific bile-acid signaling factor to immune checkpoint...
Oral-biology plagiarism network used LLMs to inflate citation counts
Researchers uncovered a preprint plagiarism network that they say uses large language models to rephrase legitimate work posted on preprint servers. The investigation, described under “Fake...
Health innovation in water management targets toxin-producing blooms
A team reported a “set it and forget it” system to stop cyanobacteria-driven algae blooms using bacteria-busting buoys. In tests described in ACS ES&T Water, the tethered buoy design removed...
Oral peptide and obesity platform competition meets regulator scrutiny
Beyond the Lilly approval itself, investors and analysts are weighing how rapidly oral GLP-1 competitors can convert regulatory gains into sustained prescriptions. The reporting tied Foundayo’s...
Federal science funding proposal puts NIH and NSF in the spotlight
The White House proposed major budget cuts to US science agencies, including a 13% reduction for the National Institutes of Health and cuts exceeding 50% for the NSF and EPA compared with current...
Infectious disease funding and research signals—economics and ROI narrative
A research advocacy group, United for Medical Research, reported that NIH grant money stimulated the US economy with a stated 250% return on investment. The report also warns that certain funding...